Pfizer's sales missed estimates for the quarter as the drugmaker tries to transition out of the pandemic. Pfizer chairman and CEO Albert Bourla discusses the path ahead for the company, including its plans for acquisitions. He speaks with Bloomberg Wall Street Week host David Westin.

Stew Leonard’s Wines & Spirits President Blake Leonard Talks Beverage Industry, Company Succession
08:03

Bob Hormats Talks Trump/Xi Summit
08:52

US Trade Representative Jamieson Greer Talks China Trade
13:52